Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neurostimulation to Improve NOWS Outcomes

NCT: NCT05129020 · ACTIVE_NOT_RECRUITING

NCT IDNCT05129020
StatusACTIVE_NOT_RECRUITING
Start Date2022-07-27
Completion2027-01-31
SponsorSpark Biomedical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to determine if tAN therapy can reduce the median number of days of oral morphine administered to an infant after start of treatment.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑